基于瘤透深度的宫状细胞癌风险因素的预后值
1Department of Gastroenterology, Shanxi Provincial Cancer Hospital, No. 3, Employee New Street, Xinghualing District, Taiyuan, 030013, China.
BMC cancer
|September 2, 2025
概括
瘤透深度会影响宫癌的预后. 虽然淋巴结转移总是一个风险,但瘤体积和阴道侵袭等因素变得更加重要,指导治疗决策.
科学领域:
- 妇科瘤学
- 癌症研究
- 病理学
背景情况:
- 宫平细胞癌的预后受到各种风险因素的影响.
- 这些因素的预后意义可能因瘤透深度而异.
研究的目的:
- 根据瘤透深度,确定风险因素的预后重要性是否不同.
- 确定患者分层和治疗计划的关键预后指标.
主要方法:
- 对621名宫平细胞癌患者进行了回顾性队列研究.
- 患者根据肌壁透分为两组:完全 (组1) 和部分 (组2).
- 多变量考克斯回归生存分析以确定独立的预后因素.
主要成果:
- 在完全透 (1组) 时,瘤体积 (> 30. 8厘米),淋巴结转移和阴道侵袭是5年生存的独立预后因素.
- 在部分透 (组2) 中,只有淋巴结转移仍然是5年生存的重要独立预后因素.
- 淋巴结转移显示,2组的死亡风险增加了290%,而1组的瘤体积和阴道侵袭显著增加了死亡率.
结论:
- 淋巴结转移是所有透深度的一致的独立预后因素.
- 随着瘤透深度的增加,瘤体积,阴道侵袭,血管干扰和病理等级的预后变得更加重要.
- 对于血清透和巨大的瘤体积或阴道侵袭的患者,应考虑术后化学放射治疗以改善结果.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.5K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
374
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
